---
figid: PMC5961736__nihms964503f1
figlink: /pmc/articles/PMC5961736/figure/F1/
number: F1
caption: Illustration of cross-communication network of BCR, PI3K, and NF-κB signaling
  pathways that harbor effective therapeutic targets in lymphoma. BCR signaling, PI3K/AKT/mTOR
  signaling, and NF-κB signaling are independent but interconnected and may form complex
  crosstalk network. One pathway may act as upstream or downstream of other pathways
  and some molecular targets function as key points and players involved in several
  pathways. These key molecules have been shown promise to be a good therapeutic target
  for effective treatment in lymphoid malignancies. (A) Tonic BCR signaling pathway
  and PI3K/AKT/mTOR signaling pathway; (B) chronic active BCR signaling; (C) canonical
  NF-κB signaling pathway; (D) noncanonical NF-κB signaling pathway. The arrows indicate
  direction of activating signaling steps; the light-colored bars indicate inhibitory
  signaling steps; the black bars show inhibition from therapeutic agents toward targets.
  BAFF-R, B-cell activating factor receptor; BCR, B-cell receptor; BTK, Bruton’s tyrosine
  kinase; CARD11, caspase recruitment domain family, member 11; IKK, IκB kinase; MALT1,
  mucosa-associated lymphoid tissue lymphoma translocation protein 1; NEMO, NF-κB
  essential modifier; NIK, NF-κB-inducing kinase; mTOR, mammalian target of rapamycin;
  PI3K, phosphatidylinositol 3 kinase; TCR, T-cell receptor; TLRs, Toll-like receptors;
  TNFR, tumor necrosis factor receptor.
pmcid: PMC5961736
papertitle: Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers
  in Lymphoid Malignancies.
reftext: Ruifang Sun, et al. Crit Rev Oncog. ;22(5-6):527-557.
pmc_ranked_result_index: '19781'
pathway_score: 0.92939
filename: nihms964503f1.jpg
figtitle: Illustration of cross-communication network of BCR, PI3K, and NFKB signaling
  pathways that harbor effective therapeutic targets in lymphoma
year: ''
organisms: Homo sapiens
ndex: 6521ce98-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5961736__nihms964503f1.html
  '@type': Dataset
  description: Illustration of cross-communication network of BCR, PI3K, and NF-κB
    signaling pathways that harbor effective therapeutic targets in lymphoma. BCR
    signaling, PI3K/AKT/mTOR signaling, and NF-κB signaling are independent but interconnected
    and may form complex crosstalk network. One pathway may act as upstream or downstream
    of other pathways and some molecular targets function as key points and players
    involved in several pathways. These key molecules have been shown promise to be
    a good therapeutic target for effective treatment in lymphoid malignancies. (A)
    Tonic BCR signaling pathway and PI3K/AKT/mTOR signaling pathway; (B) chronic active
    BCR signaling; (C) canonical NF-κB signaling pathway; (D) noncanonical NF-κB signaling
    pathway. The arrows indicate direction of activating signaling steps; the light-colored
    bars indicate inhibitory signaling steps; the black bars show inhibition from
    therapeutic agents toward targets. BAFF-R, B-cell activating factor receptor;
    BCR, B-cell receptor; BTK, Bruton’s tyrosine kinase; CARD11, caspase recruitment
    domain family, member 11; IKK, IκB kinase; MALT1, mucosa-associated lymphoid tissue
    lymphoma translocation protein 1; NEMO, NF-κB essential modifier; NIK, NF-κB-inducing
    kinase; mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol 3 kinase;
    TCR, T-cell receptor; TLRs, Toll-like receptors; TNFR, tumor necrosis factor receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF8
  - BCL10
  - MYD88
  - TNFSF13B
  - TRD
  - TRG
  - TNFRSF1A
  - TLR3
  - IKBKG
  - NFAT5
  - NFATC1
  - TRB
  - TRA
  - MAP2K6
  - SYK
  - MAP2K4
  - MTOR
  - PIK3R4
  - MAP2K7
  - BTK
  - PPP3CA
  - PPP3R1
  - BCR
  - AKT3
  - AKT1
  - AKT2
  - IL1R1
  - PIK3CB
  - PIK3R6
  - PIK3R5
  - MAPK14
  - TLR4
  - TLR5
  - TLR10
  - TLR1
  - PPP3R2
  - PPP3CB
  - PPP3CC
  - CARD11
  - CD40
  - NFKBIA
  - CHUK
  - IKBKB
  - PIK3CG
  - TLR7
  - PIK3CA
  - PIK3CD
  - TLR2
  - MAP2K3
  - TLR8
  - TLR9
  - MAPK3
  - MAPK8
  - MAP2K5
  - NFATC4
  - RELA
  - RELB
  - PIK3R3
  - MAPK1
  - TLR6
  - MAPK10
  - NFATC2
  - PTEN
  - MAPK13
  - NFATC3
  - MAPK9
  - MAPK11
  - MAPK12
  - AMG319
  - Perifosine
  - Temsirolimus
  - Ridaforolimus
  - Fostamatinib
  - GSK690693
  - MLN4924
  - Ibrutinib
  - Sirolimus
genes:
- word: BAFF,CD40,CD30,IL-1R
  symbol: CD30
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF8
  entrez: '943'
- word: BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: BAFF,CD40,CD30,IL-1R
  symbol: BAFF
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF13B
  entrez: '10673'
- word: TCR,
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR,
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR,TLR,TNFR1,EBV
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: TCR,
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR,
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BAFF,CD40,CD30,IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: CARD11
  symbol: CARD11
  source: hgnc_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: CD40,
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: IKKa
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TLR,
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
chemicals:
- word: AMG319
  source: MESH
  identifier: C000597234
- word: Perifosine
  source: MESH
  identifier: C105905
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Ridaforolimus
  source: MESH
  identifier: C515074
- word: Fostamatinib
  source: MESH
  identifier: C523665
- word: GSK690693
  source: MESH
  identifier: C528328
- word: MLN4924
  source: MESH
  identifier: C539933
- word: Ibrutinib
  source: MESH
  identifier: C551803
- word: Sirolimus
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC5961736__F1
redirect_from: /figures/PMC5961736__F1
figtype: Figure
---
